ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Arizona » Pulmonary Disease

Top Pulmonary Disease Prescribers in Arizona

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JEFFREY ARNOLD MD

Pulmonary Disease

5,088

$577K

420
359 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 58%

$113
Average prescription price

Avg: $235

M SALIM MD

Pulmonary Disease

5,018

$668K

578
427 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 58%

$133
Average prescription price

Avg: $235

CRAIG RUNDBAKEN DO

Pulmonary Disease

4,751

$915K

896
830 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 58%

$193
Average prescription price

Avg: $235

AMY SILVERTHORN M.D.

Pulmonary Disease

4,685

$944K

473
359 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 58%

$201
Average prescription price

Avg: $235

WILLIAM DISHNER DO

Pulmonary Disease

4,478

$796K

542
407 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 58%

$178
Average prescription price

Avg: $235

GAUTAM SHAH M.D.

Pulmonary Disease

4,441

$353K

395
380 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 58%

$79
Average prescription price

Avg: $235

JUDITH NEWELL RN

Pulmonary Disease

3,866

$491K

586
436 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 58%

$127
Average prescription price

Avg: $235

ANEES ARSHAD MD

Pulmonary Disease

3,798

$1.12M

547
416 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

82%
prescriptions for brand name drugs

Avg: 58%

$294
Average prescription price

Avg: $235

RAJAT WALIA MD

Pulmonary Disease

3,352

$1.3M

99
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 58%

$388
Average prescription price

Avg: $235

ABDULKADIR HOURANI MD

Pulmonary Disease

3,290

$1.36M

388
314 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 58%

$413
Average prescription price

Avg: $235

FARID GHEBLEH M.D.

Pulmonary Disease

3,190

$383K

320
256 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 58%

$120
Average prescription price

Avg: $235

LORIE LOREMAN DO

Pulmonary Disease

3,080

$677K

388
302 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

73%
prescriptions for brand name drugs

Avg: 58%

$220
Average prescription price

Avg: $235

GIRISH MEHTA MD

Pulmonary Disease

3,063

$404K

517
462 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 58%

$132
Average prescription price

Avg: $235

GEORGE PARIDES DO

Pulmonary Disease

3,047

$619K

372
289 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

66%
prescriptions for brand name drugs

Avg: 58%

$203
Average prescription price

Avg: $235

KETAN JANI M.D.

Pulmonary Disease

2,740

$414K

422
323 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 58%

$151
Average prescription price

Avg: $235

STEVEN FARBER DO

Pulmonary Disease

2,707

$475K

261
188 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 58%

$175
Average prescription price

Avg: $235

THOMAS SLOBIG MD

Pulmonary Disease

2,691

$477K

456
415 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 58%

$177
Average prescription price

Avg: $235

SHANNON VALENZUELA MD

Pulmonary Disease

2,673

$863K

361
336 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 58%

$323
Average prescription price

Avg: $235

KHALEEL SALAHUDEEN MD

Pulmonary Disease

2,542

$442K

408
366 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 58%

$174
Average prescription price

Avg: $235

GERALD SCHWARTZBERG MD

Pulmonary Disease

2,420

$283K

273
217 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 58%

$117
Average prescription price

Avg: $235

RAJ MULPURI MD

Pulmonary Disease

2,334

$357K

377
340 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 58%

$153
Average prescription price

Avg: $235

KATHERINE COSTA ACNP

Pulmonary Disease

2,294

$105K

275
247 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 58%

$46
Average prescription price

Avg: $235

SEYED JAVADPOOR MD

Pulmonary Disease

2,291

$424K

462
395 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

71%
prescriptions for brand name drugs

Avg: 58%

$185
Average prescription price

Avg: $235

AMITAB PURI MD

Pulmonary Disease

2,227

$360K

506
369 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

67%
prescriptions for brand name drugs

Avg: 58%

$162
Average prescription price

Avg: $235

ABDULLAH YONAN M.D.

Pulmonary Disease

2,152

$690K

281
198 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

75%
prescriptions for brand name drugs

Avg: 58%

$321
Average prescription price

Avg: $235

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank